Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' VANDEKERKHOF PCM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 167 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. GERRITSEN MJP; BOEZEMAN JBM; ELBERS ME; VANDEKERKHOF PCM
      DITHRANOL EMBEDDED IN CRYSTALLINE MONOGLYCERIDES COMBINED WITH PHOTOTHERAPY (UVB) - A NEW APPROACH IN THE TREATMENT OF PSORIASIS

      SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    2. VANPELT JPA; DEJONG EMGJ; BAKKER ESM; VANDEKERKHOF PCM
      EFFECTS OF SYSTEMIC TREATMENT WITH LIAROZOLE ON CUTANEOUS INFLAMMATION, EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN EXTENSIVE PLAQUE PSORIASIS

      SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    3. VANDEKERKHOF PCM
      AN UPDATE ON VITAMIN-D-3 ANALOGS IN THE TREATMENT OF PSORIASIS

      SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    4. VANDEKERKHOF PCM; STEEGERSTHEUNISSEN RPM; KUIPERS MV
      EVALUATION OF TOPICAL DRUG-TREATMENT IN PSORIASIS

      Dermatology
    5. VANDEKERKHOF PCM
      IN-VIVO EFFECTS OF VITAMIN-D-3 ANALOGS

      Journal of dermatological treatment
    6. SEYGER MMB; VANDEKERKHOF PCM; VANVLIJMENWILLEMS IMJJ; DEBAKKER ESM; ZWIERS F; DEJONG EMGJ
      THE EFFICACY OF A NEW TOPICAL TREATMENT FOR PSORIASIS - MIRAK

      JEADV. Journal of the European Academy of Dermatology and Venereology
    7. VANPELT JPA; KUIJPERS SHH; VANDEKERKHOF PCM; DEJONG EMGJ
      THE CD11B CD18-INTEGRIN IN THE PATHOGENESIS OF PSORIASIS/

      Journal of dermatological science
    8. GLADE CP; VANDERVLEUTEN CJM; VANERP PEJ; DEJONG EMJJ; VANDEKERKHOF PCM
      THE EPIDERMIS OF CHRONIC IDIOPATHIC LICHEN-PLANUS DURING TOPICAL TREATMENT WITH THE VITAMIN-D-3 ANALOG KH 1060

      Clinical and experimental dermatology
    9. VANDEKERKHOF PCM
      THE MANAGEMENT OF PSORIASIS

      Netherlands journal of medicine
    10. GERRITSEN MJP; DEJONG EMGJ; VANDEKERKHOF PCM
      LINEAR LICHEN-PLANOPILARIS OF THE FACE

      Journal of the American Academy of Dermatology
    11. KUIJPERS ALA; VANROSSUM MM; VANRUISSEN F; BERGERS M; HIEMSTRA PS; VANDEKERKHOF PCM; SCHALKWIJK J
      DECREASED LEVELS OF EPIDERMAL SKALP IN PUSTULAR FORMS OF PSORIASIS ARE CAUSED BY POSTTRANSLATIONAL MECHANISMS

      Journal of investigative dermatology
    12. KUIJPERS ALA; VANPELT HPA; BERGERS M; BOEGHEIM P; DENBAKKER JEN; SIEGENTHALER G; VANDEKERKHOF PCM; SCHALKWIJK J
      EFFECTS OF ORAL LIAROZOLE ON EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN SEVERE PLAQUE PSORIASIS - A DOUBLE-BLIND COMPARATIVE-STUDY WITHACITRETIN

      Journal of investigative dermatology
    13. VANROSSUM MM; MOMMERS JM; VANHOOIJDONK CAEM; VANERP PEJ; VANDEKERKHOF PCM
      THE RESPONSE OF DISTANT UNINVOLVED PSORIATIC SKIN AND NORMAL SKIN TO STANDARDIZED INJURY

      Journal of investigative dermatology
    14. GERRITSEN MJ; CASTELIJNS FACM; VANERP PEJ; VANDEKERKHOF PCM
      THE USE OF CLOBETASOL-17-PROPIONATE UNDER HYDROCOLLOID DRESSING IN A PSORIASIS CLEARANCE-RELAPSE MODEL - A NEW APPROACH

      Journal of investigative dermatology
    15. SEYGER MMB; VANDENHOOGEN FHJ; VANVLIJMENWILLEMS IMJJ; VANDEKERKHOF PCM; DEJONG EMGJ
      LOCALIZED AND SYSTEMIC SCLERODERMA SHOW DIFFERENT HISTOLOGICAL RESPONSES TO METHOTREXATE THERAPY

      Journal of investigative dermatology
    16. VANPELT JPA; DEJONG EMGJ; DEBAKKER ESM; VANDEKERKHOF PCM
      EFFECTS OF SYSTEMIC TREATMENT WITH LIAROZOLE ON CUTANEOUS INFLAMMATION, EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN EXTENSIVE PLAQUE PSORIASIS

      Journal of investigative dermatology
    17. MOMMERS JM; CASTELLINS FACM; SEEGERS BAMPA; VANROSSUM MM; VANHOOIJDONK CAEM; VANERP PEJ; VANDEKERKHOF PCM
      FLOW CYTOMETRIC ANALYSIS OF THE PSORIATIC EPIDERMIS AFTER LONG-TERM TREATMENT WITH 1-ALPHA,24-DIHYDROXYVITAMIN D-2 (TACALCITOL)

      Journal of investigative dermatology
    18. VANDEKERKHOF PCM
      FOLLICULAR CYSTS AND HYPERKERATOSES IN EARLY MYCOSIS-FUNGOIDES

      International journal of dermatology
    19. VANDEKERKHOF PCM; DEROOIJ M; STEIJLEN PM
      SPONTANEOUS COURSE OF HEMANGIOMAS - FACTS AND SPECULATIONS

      International journal of dermatology
    20. KUIJPERS ALA; PFUNDT R; ZEEUWEN PLJM; MOLHUIZEN HOF; MARIMAN ECM; VANDEKERKHOF PCM; SCHALKWIJK J
      SKALP ELAFIN GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH PUSTULAR FORMS OF PSORIASIS/

      Clinical genetics
    21. KRAGBALLE K; BARNES L; HAMBERG KJ; HUTCHINSON P; MURPHY F; MOLLER S; RUZICKA T; VANDEKERKHOF PCM
      CALCIPOTRIOL CREAM WITH OR WITHOUT CONCURRENT TOPICAL CORTICOSTEROID IN PSORIASIS - TOLERABILITY AND EFFICACY

      British journal of dermatology
    22. KUIJPERS ALA; VANPELT JPA; BERGERS M; BOEGHEIM PJ; DENBAKKER JEN; SIEGENTHALER G; VANDEKERKHOF PCM; SCHALKWIJK J
      THE EFFECTS OF ORAL LIAROZOLE ON EPIDERMAL PROLIFERATION AND DIFFERENTIATION IN SEVERE PLAQUE PSORIASIS ARE COMPARABLE WITH THOSE OF ACITRETIN

      British journal of dermatology
    23. VANPELT JPA; DEJONG EMGJ; SEIJGER MMB; VANHOOIJDONK CAEM; DEBAKKER ESM; VANVLIJMEN IMJJ; PARKER GL; VANERP PEJ; VANDEKERKHOF PCM
      INVESTIGATION ON A NOVEL AND SPECIFIC LEUKOTRIENE B-4 RECEPTOR ANTAGONIST IN THE TREATMENT OF STABLE PLAQUE PSORIASIS

      British journal of dermatology
    24. MOMMERS JM; CASTELIJNS FACM; SEEGERS BAMPA; VANROSSUM MM; VANHOOIJDONK CAEM; VANERP PEJ; VANDEKERKHOF PCM
      THE EFFECT OF LONG-TERM TREATMENT WITH TACALCITOL OIL THE PSORIATIC EPIDERMIS - A FLOW CYTOMETRIC ANALYSIS

      British journal of dermatology
    25. VANDEKERKHOF PCM
      THE WORONOFF ZONE SURROUNDING THE PSORIATIC PLAQUE

      British journal of dermatology
    26. GERRITSEN MJP; GRUINTJES FWG; ANDREISSEN MA; VANDERVALK PGM; VANDEKERKHOF PCM
      LICHEN SIMPLEX CHRONICUS AS A COMPLICATION OF HERPES-ZOSTER

      British journal of dermatology
    27. VANDEKERKHOF PCM; CAMBAZARD F; HUTCHINSON PE; HANEKE E; WONG E; SOUTEYRAND P; DAMSTRA RJ; COMBEMALE P; NEUMANN MHAM; CHALMERS RJG; OLSEN L; REVUZ J
      THE EFFECT OF ADDITION OF CALCIPOTRIOL OINTMENT (50 MU-G G) TO ACITRETIN THERAPY IN PSORIASIS/

      British journal of dermatology
    28. LATIJNHOUWERS MAHE; BERGERS M; KUIJPERS ALA; VANDERVLEUTEN CJM; DIJKMAN H; VANDEKERKHOF PCM; SCHALKWIJK J
      TENASCIN-C IS NOT A USEFUL MARKER FOR DISEASE-ACTIVITY IN PSORIASIS

      Acta dermato-venereologica
    29. GLADE CP; VANERP PEJ; WERNERSCHLENZKA H; VANDEKERKHOF PCM
      A CLINICAL AND FLOW CYTOMETRIC MODEL TO STUDY REMISSION AND RELAPSE IN PSORIASIS

      Acta dermato-venereologica
    30. VANDEKERKHOF PCM; RULO HFC; VANPELT JPA; VANVLIJMENWILLEMS IMJJ; DEJONG EMGJ
      EXPRESSION OF ENDOGLIN IN THE TRANSITION BETWEEN PSORIATIC UNINVOLVEDAND INVOLVED SKIN

      Acta dermato-venereologica
    31. VANDEKERKHOF PCM
      NEW ASPECTS IN THE TREATMENT OF ACNE

      EJD. European journal of dermatology
    32. VANPELT JPA; DEJONG EMGJ; VANERP PEJ; VANDEKERKHOF PCM
      DECREASED CD11B EXPRESSION ON CIRCULATING POLYMORPHONUCLEAR LEUKOCYTES IN PATIENTS WITH EXTENSIVE PLAQUE PSORIASIS

      EJD. European journal of dermatology
    33. GERRITSEN MJP; VANDEKERKHOF PCM; VANVLIJMENWILLEMS IMJJ; STEIJLEN PM
      EXPRESSION OF FILAGGRIN, INVOLUCRIN AND TENASCIN IN MONOGENIC DISORDERS OF KERATINIZATION

      EJD. European journal of dermatology
    34. CUNLIFFE WJ; VANDEKERKHOF PCM; CAPUTO R; CAVICCHINI S; COOPER A; FYRAND OL; GOLLNICK H; LAYTON AM; LEYDEN JJ; MASCARO JM; ORTONNE JP; SHALITA A
      ROACCUTANE TREATMENT GUIDELINES - RESULTS OF AN INTERNATIONAL SURVEY

      Dermatology
    35. KUIJPERS ALA; VANDOORENGEEBE RJ; VANDEKERKHOF PCM
      FAILURE OF COMBINATION THERAPY WITH ACITRETIN AND CYCLOSPORINE-A IN 3PATIENTS WITH ERYTHRODERMIC PSORIASIS

      Dermatology
    36. VANDEKERKHOF PCM; VANDERVLEUTEN CJM; GERRITSEN MJP; DEJONG EMGJ
      THE EPIDERMIS AS A TARGET FOR ANTIPSORIATIC TREATMENT - THE NIJMEGEN VIEW

      Journal of dermatological treatment
    37. VANDEKERKHOF PCM; SNATER E; VERBEEKGIJSBERS W; DULLER P; VANDERVALK PGM
      INTENSIFIED OUTPATIENT SHORT-CONTACT TREATMENT WITH DITHRANOL

      Journal of dermatological treatment
    38. VANDEKERKHOF PCM
      WHAT ARE DRY SKIN CONDITIONS

      Journal of dermatological treatment
    39. WITKAMP L; MEINARDI MMHM; BOSSUYT PMM; VANDEKERKHOF PCM; ARNOLD WP; DEHOOP D; RAMPEN FHJ; TAZELAAR DJ; KUITERS GRR; HAMMINGA B; BOELEN RE; HABETS WJM; VERBURGHVANDERZWAN N; BOS JD
      A MULTICENTER EVALUATION OF THE GUIDELINES FOR THE USE OF CYCLOSPORINE-A IN SEVERE PSORIASIS (VOL 7, PG 49, 1996)

      JEADV. Journal of the European Academy of Dermatology and Venereology
    40. GERRITSEN MJP; ELBERS ME; DEJONG EMGJ; VANDEKERKHOF PCM
      RECRUITMENT OF CYCLING EPIDERMAL-CELLS AND EXPRESSION OF FILAGGRIN, INVOLUCRIN AND TENASCIN IN THE MARGIN OF THE ACTIVE PSORIATIC PLAQUE, IN THE UNINVOLVED SKIN OF PSORIATIC PATIENTS AND IN THE NORMAL HEALTHY SKIN

      Journal of dermatological science
    41. VANDEKERKHOF PCM
      THE MANAGEMENT OF PSORIASIS - COMMENTARY

      Clinics in dermatology
    42. VANDEKERKHOF PCM
      COMBINATIONS AND COMPARISONS

      Clinics in dermatology
    43. ANDRIESSEN MPM; NIESSEN F; VANDEKERKHOF PCM; SCHALKWIJK J
      EPIDERMAL ABNORMALITIES IN HYPERTROPHIC SCARS - AN IMMUNOHISTOCHEMICAL STUDY

      Journal of investigative dermatology
    44. SWINKELS OOJ; PRINS M; BIRKER LWJ; GERRITSEN MJP; VANDERVALK PGM; VANDEKERKHOF PCM
      THE SYMPTOMLESS SKIN FOLLOWING SINGLE VERSUS MULTIPLE CHALLENGE WITH DETHRANOL 2-PERCENT CREAM

      Journal of investigative dermatology
    45. VEENHUIS RT; FEIND A; DEJONG J; RAEDERSTORFF D; VANDEKERKHOF PCM; VANDERVALK PGM
      TREATMENT OF ATOPIC-DERMATITIS WITH BORAGE OIL - CLINICAL-RESULTS ANDEFFECT ON FATTY-ACIDS IN ERYTHROCYTES, PLASMA AND EPIDERMIS

      Journal of investigative dermatology
    46. VANDEKERKHOF PCM
      TACALCITOL - A VIEWPOINT

      Drugs
    47. VANDEKERKHOF PCM
      OBITUARY - PROF. DR MALI,J.W.H

      International journal of dermatology
    48. VANDEKERKHOF PCM
      THE PSORIASIS AREA AND SEVERITY INDEX AND ALTERNATIVE APPROACHES FOR THE ASSESSMENT OF SEVERITY - PERSISTING AREAS OF CONFUSION

      British journal of dermatology
    49. GLADE CP; VANERP PEJ; BOEZEMAN JBM; VANDEKERKHOF PCM
      MULTIPARAMETER FLOW-CYTOMETRY AS A TOOL TO EVALUATE ANTIPSORIATIC THERAPY

      British journal of dermatology
    50. KUIJPERS ALA; SCHALKWIJK J; RULO HFC; PEPERKAMP JJA; VANDEKERKHOF PCM; DEJONG EMGJ
      EXTREMELY LOW-LEVELS OF EPIDERMAL SKIN-DERIVED ANTILEUCOPROTEINASE ELAFIN IN A PATIENT WITH IMPETIGO HERPETIFORMIS/

      British journal of dermatology
    51. VANDEKERKHOF PCM; DEROOIJ MJM
      MULTIPLE SQUAMOUS-CELL CARCINOMAS IN A PSORIATIC PATIENT FOLLOWING HIGH-DOSE PHOTOCHEMOTHERAPY AND CYCLOSPORINE TREATMENT - RESPONSE TO LONG-TERM ACITRETIN MAINTENANCE

      British journal of dermatology
    52. LUCKER GPH; HEREMANS AMC; BOEGHEIM PJ; VANDEKERKHOF PCM; STEIJLEN PM
      ORAL TREATMENT OF ICHTHYOSIS BY THE CYTOCHROME-P-450 INHIBITOR LIAROZOLE

      British journal of dermatology
    53. VANPELT JPA; DEJONG EMGJ; VANERP PEJ; MITCHELL MI; MARDER P; SPAETHE SM; VANHOOIJDONK CAEM; KUIJPERS ALA; VANDEKERKHOF PCM
      THE REGULATION OF CD11B INTEGRIN LEVELS ON HUMAN BLOOD LEUKOCYTES ANDLEUKOTRIENE B4-STIMULATED SKIN BY A SPECIFIC LEUKOTRIENE B4 RECEPTOR ANTAGONIST (LY293111)

      Biochemical pharmacology
    54. SEYGER MMB; VANDENBORN J; SCHALKWIJK J; VANDEKERKHOF PCM; DEJONG EMGJ
      ALTERED DISTRIBUTION OF HEPARAN-SULFATE PROTEOGLYCANS IN PSORIASIS

      Acta dermato-venereologica
    55. KUIJPERS ALA; BERGERS M; SIEGENTHALER G; ZEEUWEN PLJM; VANDEKERKHOF PCM; SCHALKWIJK J
      SKIN-DERIVED ANTILEUKOPROTEINASE (SKALP) AND EPIDERMAL FATTY-ACID-BINDING PROTEIN (E-FABP) - 2 NOVEL MARKERS OF THE PSORIATIC PHENOTYPE THAT RESPOND DIFFERENTIALLY TO TOPICAL STEROID

      Acta dermato-venereologica
    56. VANDEKERKHOF PCM
      OBITUARY - PROF DR MALI,J.W.H

      Acta dermato-venereologica
    57. DEJONG EMGJ; SEEGERS BAMPA; GULINCK MK; BOEZEMAN JBM; VANDEKERKHOF PCM
      PSORIASIS OF THE NAILS ASSOCIATED WITH DISABILITY IN A LARGE NUMBER OF PATIENTS - RESULTS OF A RECENT INTERVIEW WITH 1,728 PATIENTS

      Dermatology
    58. VANDERVALK PGM; SNATER E; VERBEEKGIJSBERS W; DULLER P; VANDEKERKHOF PCM
      OUTPATIENT TREATMENT OF ATOPIC-DERMATITIS WITH CRUDE COAL-TAR

      Dermatology
    59. KUIJPERS ALA; VANDOORENGREEBE RJ; VANDEKERKHOF PCM
      ACRODERMATITIS CONTINUA OF HALLOPEAU - RESPONSE TO COMBINED TREATMENTWITH ACITRETIN AND CALCIPOTRIOL OINTMENT

      Dermatology
    60. VANDEKERKHOF PCM; VANERP PEJ
      THE ROLE OF EPIDERMAL PROLIFERATION IN THE PATHOGENESIS OF PSORIASIS

      Skin pharmacology
    61. VANDERVLEUTEN CJM; SNIJDERS CGEM; DEJONG EMGJ; VANDEKERKHOF PCM
      EFFECTS OF CALCIPOTRIOL AND CLOBETASOL-17-PROPIONATE ON UVB-IRRADIATED HUMAN SKIN - AN IMMUNOHISTOCHEMICAL STUDY

      Skin pharmacology
    62. VANDEKERKHOF PCM; VANPELT H; LUCKER GPH; STEIJLEN PM; HEREMANS A
      TOPICAL R-85355, A POTENT AND SELECTIVE 5-LIPOXYGENASE INHIBITOR, FAILS TO IMPROVE PSORIASIS

      Skin pharmacology
    63. LUCKER GPH; VANDEKERKHOF PCM; CASTELIJNS FACM; STEIJLEN PM
      TOPICAL TREATMENT OF DARIERS-DISEASE WITH 13-CIS-RETINOIC ACID - A CLINICAL AND IMMUNOHISTOCHEMICAL STUDY

      Journal of dermatological treatment
    64. VANDEKERKHOF PCM; GERRITSEN MJP; VANDOORENGREEBE RJ; DEJONG EMGJ
      WHAT IS NEW IN THE TREATMENT OF PSORIASIS

      Journal of dermatological treatment
    65. VANDEKERKHOF PCM; WITTENHORST M; GERRITSEN MJP; DEJONG EMGJ; LUCKER GPH; STEYLEN PM
      POSSIBLE INDICATIONS FOR VITAMIN-D-3 ANALOGS IN CONDITIONS OTHER THANPSORIASIS-VULGARIS

      Journal of dermatological treatment
    66. VANDEKERKHOF PCM; VANHARTEN J; VERJANS H
      A LONG-TERM ASSESSMENT OF THE SAFETY AND TOLERABILITY OF CALCITRIOL OINTMENT IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS

      Journal of dermatological treatment
    67. VANDERVLEUTEN CJM; KROOT EJA; DEJONG EMGJ; VANDEKERKHOF PCM
      THE IMMUNOHISTOCHEMICAL EFFECTS OF A SINGLE CHALLENGE WITH AN INTERMEDIATE-DOSE OF ULTRAVIOLET-B ON NORMAL HUMAN SKIN

      Archives of dermatological research
    68. VANBERGEN BH; ANDRIESSEN MPM; SPRUIJT KIJ; VANDEKERKHOF PCM; SCHALKWIJK J
      EXPRESSION OF SKALP ELAFIN DURING WOUND-HEALING IN HUMAN SKIN/

      Archives of dermatological research
    69. VANDERVLEUTEN CJM; DEJONG EMGJ; VANDEKERKHOF PCM
      EPIDERMAL DIFFERENTIATION CHARACTERISTICS OF THE PSORIATIC PLAQUE DURING TREATMENT WITH CALCIPOTRIOL

      Archives of dermatological research
    70. GLADE CP; SEEGERS BAMPA; MEULEN EFJ; VANHOOIJDONK CAEM; VANERP PEJ; VANDEKERKHOF PCM
      MULTIPARAMETER FLOW CYTOMETRIC CHARACTERIZATION OF EPIDERMAL-CELL SUSPENSIONS PREPARED FROM NORMAL AND HYPERPROLIFERATIVE HUMAN SKIN USING AN OPTIMIZED THERMOLYSIN TRYPSIN PROTOCOL

      Archives of dermatological research
    71. KUIJPERS ALA; ZEEUWEN PLJM; DEJONGH GJ; VANDEKERKHOF PCM; ALKEMADE HAC; SCHALKWIJK J
      SKIN-DERIVED ANTILEUKOPROTEINASE (SKALP) IS DECREASED IN PUSTULAR FORMS OF PSORIASIS - A CLUE TO THE PATHOGENESIS OF PUSTULE FORMATION

      Archives of dermatological research
    72. LE M; SCHALKWIJK J; SIEGENTHALER G; VANDEKERKHOF PCM; VEERKAMP JH; VANDERVALK PGM
      CHANGES IN KERATINOCYTE DIFFERENTIATION FOLLOWING MILD IRRITATION BY SODIUM DODECYL-SULFATE

      Archives of dermatological research
    73. VANDERVLEUTEN CJM; DEJONG EMGJ; VANDEKERKHOF PCM
      EPIDERMAL DIFFERENTIATION CHARACTERISTICS OF THE PSORIATIC PLAQUE DURING SHORT-CONTACT TREATMENT WITH DITHRANOL CREAM

      Clinical and experimental dermatology
    74. OOSTENBRINK JH; COHEN EB; STEIJLEN PM; VANDEKERKHOF PCM
      ORAL-CONTRACEPTIVES IN THE TREATMENT OF DARIER-WHITE-DISEASE - A CASE-REPORT AND REVIEW OF THE LITERATURE

      Clinical and experimental dermatology
    75. VANDEKERKHOF PCM; GERRITSEN MJP; DEJONG EMGJ
      TRANSITION FROM SYMPTOMLESS TO LESIONAL PSORIATIC SKIN

      Clinical and experimental dermatology
    76. FEINDKOOPMANS A; VANDERVALK PGM; STEIJLEN PM; VANDEKERKHOF PCM
      TOXIC PUSTULODERMA ASSOCIATED WITH CLEMASTINE THERAPY

      Clinical and experimental dermatology
    77. FEINDKOOPMANS AG; LUCKER GPH; VANDEKERKHOF PCM
      ACQUIRED ICHTHYOSIFORM ERYTHRODERMA AND SARCOIDOSIS

      Journal of the American Academy of Dermatology
    78. GERRITSEN MJP; VANERP PEJ; VANDEKERKHOF PCM
      TRANSGLUTAMINASE EXPRESSION IN LESIONAL SKIN, DISTANT CLINICALLY UNINVOLVED SKIN, AND IN THE MARGIN ZONE OF PSORIASIS

      Journal of investigative dermatology
    79. KUIJPERS ALA; PFUNDT R; ZEEUWEN PLJM; MOLHUIZEN HOF; VANDEKERKHOF PCM; SCHALKWIJK J
      LACK OF ASSOCIATION OF SKIN-DERIVED ANTILEUKOPROTEINASE ELAFIN GENE POLYMORPHISM WITH DIFFERENT FORMS OF PSORIASIS/

      Journal of investigative dermatology
    80. VANPELT JPA; KUIJPERS SHH; DEJONG EMGJ; VANDEKERKHOF PCM
      DISTRIBUTION OF THE CD11B CD18 INTEGRIN AND ITS LIGAND ICAM-1 IN THE MARGIN OF THE SPREADING PSORIATIC PLAQUE/

      Journal of investigative dermatology
    81. GLADE CP; VANERP PEJ; VANDEKERKHOF PCM
      TREATMENT OF PSORIASIS-VULGARIS WITH CALCIPOTRIOL CREAM AND TOPICAL CORTICOSTEROIDS - A COMPARATIVE FLOW CYTOMETRIC STUDY

      Journal of investigative dermatology
    82. VANDERVLEUTEN CJM; SNIJDERS CGEM; DEJONG EMGJ; VANDEKERKHOF PCM
      THE EFFECTS OF CALCIPOTRIOL AND CLOBETASOL-17-PROPIONATE ON ULTRAVIOLET-B IRRADIATED HUMAN SKIN - AN IMMUNOHISTOCHEMICAL STUDY

      Journal of investigative dermatology
    83. VANDOORENGREEBE RJ; VANDEKERKHOF PCM
      RETINOIDS AND HYPEROSTOSIS - REPLY

      British journal of dermatology
    84. VANDEKERKHOF PCM; WERFEL T; HAUSTEIN UF; LUGER T; CZARNETZKI BM; NIEMANN R; PLANITZSTENZEL V
      TACALCITOL OINTMENT IN THE TREATMENT OF PSORIASIS-VULGARIS - A MULTICENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND-STUDY ON EFFICACY AND SAFETY

      British journal of dermatology
    85. GLADE CP; VANERP PEJ; VANDEKERKHOF PCM
      EPIDERMAL-CELL DNA CONTENT AND INTERMEDIATE FILAMENTS KERATIN-10 AND VIMENTIN AFTER TREATMENT OF PSORIASIS WITH CALCIPOTRIOL CREAM ONCE-DAILY, TWICE-DAILY AND IN COMBINATION WITH CLOBETASONE 17-BUTYRATE CREAM OR BETAMETHASONE 17-VALERATE CREAM - A COMPARATIVE FLOW CYTOMETRIC STUDY

      British journal of dermatology
    86. LANGNER A; ASHTON P; VANDEKERKHOF PCM; VERJANS H
      A LONG-TERM MULTICENTER ASSESSMENT OF THE SAFETY AND TOLERABILITY OF CALCITRIOL OINTMENT IN THE TREATMENT OF CHRONIC PLAQUE PSORIASIS

      British journal of dermatology
    87. VANDOORENGREEBE RJ; KUIJPERS ALA; BUIJS WCAM; KNIEST PHM; CORSTENS FHM; NAGENGAST FM; DEBOO T; WILLEMS JL; DULLER P; VANDEKERKHOF PCM
      THE VALUE OF DYNAMIC HEPATIC SCINTIGRAPHY AND SERUM AMINOTERMINAL PROPEPTIDE OF TYPE-III PROCOLLAGEN FOR EARLY DETECTION OF METHOTREXATE-INDUCED HEPATIC DAMAGE IN PSORIASIS PATIENTS

      British journal of dermatology
    88. DEJONG EMGJ; VANDEKERKHOF PCM
      COEXISTENCE OF PALMOPLANTAR LICHEN-PLANUS AND LUPUS-ERYTHEMATOSUS WITH RESPONSE TO TREATMENT USING ACITRETIN

      British journal of dermatology
    89. VANDOORENGREEBE RJ; LEMMENS JAM; DEBOO T; HANGX NMA; KUIJPERS ALA; VANDEKERKHOF PCM
      PROLONGED TREATMENT WITH ORAL RETINOIDS IN ADULTS - NO INFLUENCE ON THE FREQUENCY AND SEVERITY OF SPINAL ABNORMALITIES

      British journal of dermatology
    90. VANDERVLEUTEN CJM; GERRITSEN MJP; DEJONG EMGJ; ELBERS M; DEJONGH GJ; VANDEKERKHOF PCM
      A NOVEL DITHRANOL FORMULATION (MICANOL) - THE EFFECTS OF MONOTHERAPY AND UVB COMBINATION THERAPY ON EPIDERMAL DIFFERENTIATION, PROLIFERATION AND CUTANEOUS INFLAMMATION IN PSORIASIS-VULGARIS

      Acta dermato-venereologica
    91. LUCKER GPH; STEIJLEN PM; SUYKERBUYK EJA; KRAGBALLE K; BRANDRUP F; VANDEKERKHOF PCM
      FLOW-CYTOMETRIC INVESTIGATION OF EPIDERMAL-CELL CHARACTERISTICS IN MONOGENIC DISORDERS OF KERATINIZATION AND THEIR MODULATION BY TOPICAL CALCIPOTRIOL TREATMENT

      Acta dermato-venereologica
    92. GERRITSEN MJP; VANPELT JPA; VANDEKERKHOF PCM
      RESPONSE OF THE CLINICALLY UNINVOLVED SKIN OF PSORIATIC PATIENTS TO TAPE STRIPPING DURING ACITRETIN TREATMENT

      Acta dermato-venereologica
    93. VANDERVLEUTEN CJM; GERRITSEN MJP; STEIJLEN PM; DEJONG EMGJ; VANDEKERKHOF PCM
      A THERAPEUTIC APPROACH TO ERYTHRODERMIC PSORIASIS - REPORT OF A CASE AND A DISCUSSION OF THERAPEUTIC OPTIONS

      Acta dermato-venereologica
    94. VANDERVLEUTEN CJM; DEJONG EMGJ; RULO EHFC; GERRITSEN MJP; VANDEKERKHOF PCM
      INPATIENT TREATMENT WITH CALCIPOTRIOL VERSUS DITHRANOL IN REFRACTORY PSORIASIS

      EJD. European journal of dermatology
    95. LUCKER GPH; VANDEKERKHOF PCM; CASTELIJNS FACM; VANDIJK MR; SCHALKWIJK LJM; STEIJLEN PM
      TOPICAL TREATMENT OF ICHTHYOSES WITH 13-CIS RETINOIC ACID - A CLINICAL AND IMMUNOHISTOCHEMICAL STUDY

      EJD. European journal of dermatology
    96. VANDEKERKHOF PCM; STEIJLEN PM
      IGA DEFICIENCY AND PSORIASIS RELEVANCE OF IGA IN THE PATHOGENESIS OF PSORIASIS

      Dermatology
    97. VANDEKERKHOF PCM; VANBAAR HMJ
      COOCCURRENCE OF PLASMA-CELL ORIFICIAL MUCOSITIS AND PLASMOACANTHOMA -REPORT OF A CASE AND REVIEW OF THE LITERATURE

      Dermatology
    98. LUCKER GPH; VANDEKERKHOF PCM; CRUYSBERG JRM; DERKINDEREN DJ; STEIJLEN PM
      TOPICAL TREATMENT OF SJOGREN-LARSSON SYNDROME WITH CALCIPOTRIOL

      Dermatology
    99. VANDEKERKHOF PCM; GOOS M; CHRISTOPHERS E; BAUDIN M; DUPUY P
      INHIBITOR OF THE RELEASE OF MAST-CELL MEDIATORS DOES NOT IMPROVE THE PSORIATIC PLAQUE

      Skin pharmacology
    100. WOLSKA H; LAWS S; SCHULZKIESOW M; GROSSMAN R; JABLONSKA S; STADLER R; VANDEKERKHOF PCM; DUPUY P
      CLINICAL-EVALUATION OF A PAF-ANTAGONIST IN PSORIASIS-VULGARIS

      Journal of dermatological treatment


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 01:35:06